ZEVTERA Trademark

Trademark Overview

On Tuesday, July 27, 2021, a trademark application was filed for ZEVTERA with the United States Patent and Trademark Office. The USPTO has given the ZEVTERA trademark a serial number of 90849714. The federal status of this trademark filing is REGISTERED as of Tuesday, April 21, 2026. This trademark is owned by Basilea Pharmaceutica International Ltd.. The ZEVTERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, dermatological disorders, cardiovascular diseases
zevtera

General Information

Serial Number90849714
Word MarkZEVTERA
Filing DateTuesday, July 27, 2021
Status700 - REGISTERED
Status DateTuesday, April 21, 2026
Registration Number8223006
Registration DateTuesday, April 21, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, dermatological disorders, cardiovascular diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code005
First Use Anywhere DateWednesday, April 30, 2025
First Use In Commerce DateWednesday, April 30, 2025

Trademark Owner History

Party NameBASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressALLSCHWIL 4123
CH
Party NameBASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressALLSCHWIL 4123
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4058
CH
Party NameBasilea Pharmaceutica International Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel 4058
CH

Trademark Events

Event DateEvent Description
Friday, July 30, 2021NEW APPLICATION ENTERED
Friday, September 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 22, 2022ASSIGNED TO EXAMINER
Friday, April 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 14, 2022NOTICE OF ALLOWANCE CANCELLED
Wednesday, September 14, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, September 20, 2022NON-FINAL ACTION WRITTEN
Tuesday, September 20, 2022NON-FINAL ACTION E-MAILED
Tuesday, September 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 28, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 8, 2023SOU EXTENSION 1 FILED
Tuesday, August 8, 2023SOU EXTENSION 1 GRANTED
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 16, 2024SOU EXTENSION 2 FILED
Friday, February 16, 2024SOU EXTENSION 2 GRANTED
Saturday, February 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024SOU EXTENSION 3 FILED
Wednesday, August 14, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 12, 2025SOU TEAS EXTENSION RECEIVED
Thursday, February 13, 2025SOU EXTENSION 4 FILED
Thursday, February 13, 2025SOU EXTENSION 4 GRANTED
Thursday, February 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 18, 2025SOU TEAS EXTENSION RECEIVED
Monday, August 18, 2025SOU EXTENSION 5 FILED
Thursday, September 25, 2025SOU EXTENSION 5 GRANTED
Friday, September 26, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 26, 2025TEAS STATEMENT OF USE RECEIVED
Friday, March 27, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 26, 2025USE AMENDMENT FILED
Saturday, March 28, 2026STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 1, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 1, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 21, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, April 21, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

zevtera diseases dermatological cardiovascular disorders infectious preparations substances treatment pharmaceutical